-
1
-
-
28344454000
-
Molecular classification and molecular forecasting of breast cancer: ready for clinical application?
-
COI: 1:CAS:528:DC%2BD2MXhtF2nsLrJ, PID: 16145060
-
Brenton JD, Carey LA, Ahmed AA, Caldas C. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol. 2005;23(29):7350-7360.
-
(2005)
J Clin Oncol.
, vol.23
, Issue.29
, pp. 7350-7360
-
-
Brenton, J.D.1
Carey, L.A.2
Ahmed, A.A.3
Caldas, C.4
-
2
-
-
0034680102
-
Molecular portraits of human breast tumours
-
COI: 1:CAS:528:DC%2BD3cXmt1CnsLw%3D, PID: 10963602
-
Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747-752.
-
(2000)
Nature.
, vol.406
, Issue.6797
, pp. 747-752
-
-
Perou, C.M.1
Sorlie, T.2
Eisen, M.B.3
-
3
-
-
84901586809
-
Basal-like and triple-negative breast cancers: searching for positives among many negatives
-
PID: 24882351
-
Alluri P, Newman LA. Basal-like and triple-negative breast cancers: searching for positives among many negatives. Surg Oncol Clin N Am. 2014;23(3):567-577.
-
(2014)
Surg Oncol Clin N Am.
, vol.23
, Issue.3
, pp. 567-577
-
-
Alluri, P.1
Newman, L.A.2
-
4
-
-
79959503213
-
Triple-negative breast cancer: an unmet medical need
-
PID: 21278435
-
Hudis CA, Gianni L. Triple-negative breast cancer: an unmet medical need. Oncologist. 2011;16 Suppl 1:1-11.
-
(2011)
Oncologist.
, vol.16
, pp. 1-11
-
-
Hudis, C.A.1
Gianni, L.2
-
5
-
-
79960015997
-
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
-
COI: 1:CAS:528:DC%2BC3MXovVKgu78%3D, PID: 21633166
-
Lehmann BD, Bauer JA, Chen X, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121(7):2750–67.
-
(2011)
J Clin Invest.
, vol.121
, Issue.7
, pp. 2750-2767
-
-
Lehmann, B.D.1
Bauer, J.A.2
Chen, X.3
-
6
-
-
84864579879
-
TNBC type: a subtyping tool for triple-negative breast cancer
-
PID: 22872785
-
Chen X, Li J, Gray WH, et al. TNBC type: a subtyping tool for triple-negative breast cancer. Cancer Inform. 2012;11:147-156.
-
(2012)
Cancer Inform.
, vol.11
, pp. 147-156
-
-
Chen, X.1
Li, J.2
Gray, W.H.3
-
7
-
-
84886412350
-
Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes
-
COI: 1:CAS:528:DC%2BC3sXhsFynsL7P, PID: 23948975
-
Masuda H, Baggerly KA, Wang Y, et al. Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes. Clin Cancer Res. 2013;19(19):5533-5540.
-
(2013)
Clin Cancer Res.
, vol.19
, Issue.19
, pp. 5533-5540
-
-
Masuda, H.1
Baggerly, K.A.2
Wang, Y.3
-
8
-
-
84880379664
-
The role of the androgen receptor in triple-negative breast cancer
-
COI: 1:CAS:528:DC%2BC3sXhtVGltLjL, PID: 23826776
-
Shah PD, Gucalp A, Traina TA. The role of the androgen receptor in triple-negative breast cancer. Womens Health (Lond Engl). 2013;9(4):351-360.
-
(2013)
Womens Health (Lond Engl).
, vol.9
, Issue.4
, pp. 351-360
-
-
Shah, P.D.1
Gucalp, A.2
Traina, T.A.3
-
9
-
-
84867032762
-
Androgen receptor in triple negative breast cancer
-
COI: 1:CAS:528:DC%2BC38XhslCktLrM, PID: 22982153
-
McNamara KM, Yoda T, Takagi K, Miki Y, Suzuki T, Sasano H. Androgen receptor in triple negative breast cancer. J Steroid Biochem Mol Biol. 2013;133:66-76.
-
(2013)
J Steroid Biochem Mol Biol.
, vol.133
, pp. 66-76
-
-
McNamara, K.M.1
Yoda, T.2
Takagi, K.3
Miki, Y.4
Suzuki, T.5
Sasano, H.6
-
10
-
-
84896702428
-
Androgen receptor-positive triple negative breast cancer: a unique breast cancer subtype
-
PID: 24046116
-
McGhan LJ, McCullough AE, Protheroe CA, et al. Androgen receptor-positive triple negative breast cancer: a unique breast cancer subtype. Ann Surg Oncol. 2014;21(2):361–7.
-
(2014)
Ann Surg Oncol.
, vol.21
, Issue.2
, pp. 361-367
-
-
McGhan, L.J.1
McCullough, A.E.2
Protheroe, C.A.3
-
11
-
-
84886425456
-
Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer
-
COI: 1:CAS:528:DC%2BC3sXhsFynsL7M, PID: 23965901
-
Gucalp A, Tolaney S, Isakoff SJ, et al. Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer. Clin Cancer Res. 2013;19(19):5505-5512.
-
(2013)
Clin Cancer Res.
, vol.19
, Issue.19
, pp. 5505-5512
-
-
Gucalp, A.1
Tolaney, S.2
Isakoff, S.J.3
-
12
-
-
77149129286
-
Triple-negative breast cancer: role of the androgen receptor
-
COI: 1:CAS:528:DC%2BC3cXjvVKktL0%3D, PID: 20164692
-
Gucalp A, Traina TA. Triple-negative breast cancer: role of the androgen receptor. Cancer J. 2010;16(1):62-65.
-
(2010)
Cancer J.
, vol.16
, Issue.1
, pp. 62-65
-
-
Gucalp, A.1
Traina, T.A.2
-
13
-
-
84863795169
-
Triple-negative breast cancer: adjuvant therapeutic options
-
PID: 22312556
-
Gucalp A, Traina TA. Triple-negative breast cancer: adjuvant therapeutic options. Chemother Res Pract. 2011;2011:696208.
-
(2011)
Chemother Res Pract.
, vol.2011
, pp. 696208
-
-
Gucalp, A.1
Traina, T.A.2
-
14
-
-
84890254448
-
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update
-
PID: 24101045
-
Wolff AC, Hammond ME, Hicks DG, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31(31):3997-4013.
-
(2013)
J Clin Oncol.
, vol.31
, Issue.31
, pp. 3997-4013
-
-
Wolff, A.C.1
Hammond, M.E.2
Hicks, D.G.3
-
15
-
-
77954526150
-
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
-
PID: 20404251
-
Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28(16):2784-2795.
-
(2010)
J Clin Oncol.
, vol.28
, Issue.16
, pp. 2784-2795
-
-
Hammond, M.E.1
Hayes, D.F.2
Dowsett, M.3
-
16
-
-
84921411055
-
The anti-androgen drug dutasteride renders triple negative breast cancer cells more sensitive to chemotherapy via inhibition of HIF-1alpha-/VEGF-signaling
-
von Wahlde MK, Hulsewig C, Ruckert C, Götte M, Kiesel L, Bernemann C. The anti-androgen drug dutasteride renders triple negative breast cancer cells more sensitive to chemotherapy via inhibition of HIF-1alpha-/VEGF-signaling. Gynecol Endocrinol. 2015;31(2):160–4.
-
(2015)
Gynecol Endocrinol.
, vol.31
, Issue.2
, pp. 160-164
-
-
von Wahlde, M.K.1
Hulsewig, C.2
Ruckert, C.3
Götte, M.4
Kiesel, L.5
Bernemann, C.6
-
17
-
-
35848955428
-
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
-
COI: 1:CAS:528:DC%2BD2sXhsVahtrvF, PID: 18371393
-
Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007;1(5):555-567.
-
(2007)
Cell Stem Cell.
, vol.1
, Issue.5
, pp. 555-567
-
-
Ginestier, C.1
Hur, M.H.2
Charafe-Jauffret, E.3
-
18
-
-
84876420770
-
Androgenic pathway in triple negative invasive ductal tumors: its correlation with tumor cell proliferation
-
COI: 1:CAS:528:DC%2BC3sXlvVCjs7o%3D, PID: 23373898
-
McNamara KM, Yoda T, Miki Y, et al. Androgenic pathway in triple negative invasive ductal tumors: its correlation with tumor cell proliferation. Cancer Sci. 2013;104(5):639-646.
-
(2013)
Cancer Sci.
, vol.104
, Issue.5
, pp. 639-646
-
-
McNamara, K.M.1
Yoda, T.2
Miki, Y.3
-
19
-
-
84896710159
-
Loss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancer
-
COI: 1:CAS:528:DC%2BC2cXjvV2jtb4%3D, PID: 23929266
-
Thike AA, Yong-Zheng Chong L, Cheok PY, et al. Loss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancer. Mod Pathol. 2014;27(3):352–60.
-
(2014)
Mod Pathol.
, vol.27
, Issue.3
, pp. 352-360
-
-
Thike, A.A.1
Yong-Zheng Chong, L.2
Cheok, P.Y.3
-
20
-
-
78249243445
-
African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study
-
PID: 20629078
-
Stark A, Kleer CG, Martin I, et al. African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study. Cancer. 2010;116(21):4926-4932.
-
(2010)
Cancer.
, vol.116
, Issue.21
, pp. 4926-4932
-
-
Stark, A.1
Kleer, C.G.2
Martin, I.3
-
21
-
-
84872914956
-
Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women
-
COI: 1:CAS:528:DC%2BC3sXhsVWrsr0%3D, PID: 22930220
-
Schwartz T, Stark A, Pang J, et al. Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women. Cancer. 2013;119(3):488-494.
-
(2013)
Cancer.
, vol.119
, Issue.3
, pp. 488-494
-
-
Schwartz, T.1
Stark, A.2
Pang, J.3
-
22
-
-
84892632994
-
Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis
-
Vera-Badillo FE, Templeton AJ, de Gouveia P, et al. Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(1):djt319.
-
(2014)
J Natl Cancer Inst.
, vol.106
, Issue.1
, pp. 319
-
-
Vera-Badillo, F.E.1
Templeton, A.J.2
de Gouveia, P.3
|